UBS Group’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q3
Sell
-451,615
Closed -$83M 9432
2021
Q2
$83M Buy
451,615
+129,976
+40% +$23.9M 0.03% 455
2021
Q1
$49.2M Buy
321,639
+206,093
+178% +$31.5M 0.02% 628
2020
Q4
$18.1M Sell
115,546
-759,985
-87% -$119M 0.01% 1057
2020
Q3
$100M Buy
875,531
+416,889
+91% +$47.7M 0.04% 310
2020
Q2
$51.5M Sell
458,642
-207,113
-31% -$23.2M 0.02% 464
2020
Q1
$59.8M Sell
665,755
-668,638
-50% -$60M 0.03% 373
2019
Q4
$144M Buy
1,334,393
+746,516
+127% +$80.7M 0.05% 269
2019
Q3
$57.6M Buy
587,877
+333,696
+131% +$32.7M 0.02% 501
2019
Q2
$33.3M Buy
254,181
+17,371
+7% +$2.28M 0.01% 729
2019
Q1
$32M Sell
236,810
-6,103
-3% -$825K 0.01% 716
2018
Q4
$23.7M Sell
242,913
-129,516
-35% -$12.6M 0.01% 750
2018
Q3
$51.8M Buy
372,429
+110,923
+42% +$15.4M 0.02% 515
2018
Q2
$32.5M Sell
261,506
-366,873
-58% -$45.5M 0.01% 703
2018
Q1
$70M Sell
628,379
-151,629
-19% -$16.9M 0.03% 389
2017
Q4
$93.3M Buy
780,008
+319,853
+70% +$38.3M 0.04% 322
2017
Q3
$64.6M Buy
460,155
+59,551
+15% +$8.35M 0.03% 389
2017
Q2
$48.7M Buy
400,604
+342,732
+592% +$41.7M 0.03% 448
2017
Q1
$7.02M Sell
57,872
-92,889
-62% -$11.3M ﹤0.01% 1402
2016
Q4
$18.4M Buy
150,761
+97,824
+185% +$12M 0.01% 801
2016
Q3
$6.49M Sell
52,937
-40,530
-43% -$4.97M ﹤0.01% 1371
2016
Q2
$10.9M Sell
93,467
-3,234
-3% -$378K 0.01% 1017
2016
Q1
$13.5M Sell
96,701
-145,192
-60% -$20.2M 0.01% 888
2015
Q4
$46.1M Buy
241,893
+135,541
+127% +$25.9M 0.03% 435
2015
Q3
$16.6M Sell
106,352
-35,573
-25% -$5.56M 0.01% 791
2015
Q2
$25.7M Sell
141,925
-70,524
-33% -$12.7M 0.02% 645
2015
Q1
$36.8M Sell
212,449
-28,846
-12% -$5M 0.03% 517
2014
Q4
$44.6M Buy
+241,295
New +$44.6M 0.03% 470